Aperio Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $149K | Sell |
27,556
-6,346
| -19% | -$34.3K | ﹤0.01% | 2353 |
|
|
2020
Q3 | $271K | Buy |
33,902
+10,575
| +45% | +$84.5K | ﹤0.01% | 2110 |
|
|
2020
Q2 | $234K | Buy |
23,327
+4,729
| +25% | +$47.4K | ﹤0.01% | 2130 |
|
|
2020
Q1 | $51K | Buy |
+18,598
| New | +$51K | ﹤0.01% | 2277 |
|
|
2019
Q4 | – | Sell |
-19,581
| Closed | -$30K | – | 2325 |
|
|
2019
Q3 | $30K | Sell |
19,581
-2,411
| -11% | -$3.69K | ﹤0.01% | 2294 |
|
|
2019
Q2 | $88K | Buy |
+21,992
| New | +$88K | ﹤0.01% | 2416 |
|
|
2018
Q4 | – | Sell |
-10,789
| Closed | -$146K | – | 2289 |
|
|
2018
Q3 | $146K | Buy |
+10,789
| New | +$146K | ﹤0.01% | 2224 |
|